A Study of GC203 TIL in Advanced Gynecologic Tumors (10hospital)
Conditions
- Advanced Gynecologic Tumors
- TIL Engineered With Membrane-Binding Cytokine
- Treatment Side Effects
- Effects of Immunotherapy
Interventions
- BIOLOGICAL: Membrane Bound Cytokine Modified TIL
Sponsor
Shanghai Juncell Therapeutics
Collaborators